U.S. markets closed
  • S&P Futures

    4,594.50
    +4.50 (+0.10%)
     
  • Dow Futures

    35,262.00
    +50.00 (+0.14%)
     
  • Nasdaq Futures

    15,847.50
    +4.75 (+0.03%)
     
  • Russell 2000 Futures

    2,206.80
    +3.20 (+0.15%)
     
  • Crude Oil

    70.12
    +0.63 (+0.91%)
     
  • Gold

    1,780.50
    +1.00 (+0.06%)
     
  • Silver

    22.31
    +0.05 (+0.21%)
     
  • EUR/USD

    1.1294
    +0.0008 (+0.07%)
     
  • 10-Yr Bond

    1.4340
    +0.0910 (+6.78%)
     
  • Vix

    27.18
    -3.49 (-11.38%)
     
  • GBP/USD

    1.3279
    +0.0018 (+0.14%)
     
  • USD/JPY

    113.4780
    -0.0120 (-0.01%)
     
  • BTC-USD

    50,803.05
    +1,796.16 (+3.67%)
     
  • CMC Crypto 200

    1,310.00
    +49.84 (+3.96%)
     
  • FTSE 100

    7,232.28
    +109.96 (+1.54%)
     
  • Nikkei 225

    28,282.01
    +354.64 (+1.27%)
     

35 Stocks Moving In Friday's Mid-Day Session

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·5 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Gainers

  • Biomerica, Inc. (NASDAQ: BMRA) shares climbed 38.3% to $6.23. Biomerica entered into a Supplier Agreement with Walmart to sell its EZ Detect colorectal disease screening test within the Walmart retail system.

  • Progenity, Inc. (NASDAQ: PROG) gained 23% to $1.87 after jumping over 40% on Thursday.

  • Atea Pharmaceuticals, Inc. (NASDAQ: AVIR) climbed 21.3% to $42.52 following data from Merck & Co's investigational oral antiviral molnupiravir, which boosted sentiment for Atea Pharmaceutical's AT-527, an oral antiviral drug candidate.

  • Sono-Tek Corporation (NASDAQ: SOTK) surged 14.4% to $4.69.

  • Ramaco Resources, Inc. (NASDAQ: METC) gained 14% to $14.03.

  • Salem Media Group, Inc. (NASDAQ: SALM) rose 13.7% to $4.22.

  • Quotient Limited (NASDAQ: QTNT) gained 13.2% to $2.65. Quotient reported commencement of review process of expanded immunohematology technical file dossier by European Notified Body.

  • Bitfarms Ltd. (NASDAQ: BITF) surged 13% to $4.8050 amid an increase in the price of Bitcoin and Ethereum.

  • Silverback Therapeutics, Inc. (NASDAQ: SBTX) gained 12.6% to $11.24.

  • SunPower Corporation (NASDAQ: SPWR) rose 11.9% to $25.36. SunPower will replace Cimarex Energy in the S&P MidCap 400 effective on Tuesday, October 5.

  • Luby's, Inc. (NYSE: LUB) gained 11.4% to $4.6550.

  • Merck & Co., Inc. (NYSE: MRK) jumped 9.4% to $82.17 after the company and Ridgeback announced investigational oral antiviral molnupiravir reduced risk of hospitalization or death by about 50% versus the placebo for patients with mild to moderate COVID-19 in Phase 3 interim analysis.

  • Iterum Therapeutics plc (NASDAQ: ITRM) gained 8.2% to $0.6040 after dropping over 8% on Thursday.

  • QuickLogic Corporation (NASDAQ: QUIK) rose 8.2% to $5.80. QuickLogic reported a strategic investment by current shareholders. The company said it expects Q3 revenue of $3.8 million to $3.9 million.

  • Molecular Data Inc. (NASDAQ: MKD) rose 8.4% to $0.3810. Molecular Data recently closed its $15 million registered direct offering.

  • Aeterna Zentaris Inc. (NASDAQ: AEZS) rose 8.9% to $0.8167 after climbing over 25% on Thursday.

Check out these big penny stock gainers and losers

Losers

  • Omeros Corporation (NASDAQ: OMER) fell 43.5% to $7.79 after the company announced the FDA notified it that they identified deficiencies that preclude discussion of labeling and post-marketing requirements/commitments at this time.

  • Spire Global, Inc.. (NYSE: SPIR) shares tumbled 43.3% to $7.11. Spire Global, Inc. recently appointed Dr. Kevin Petty as Vice President of Weather.

  • Adagio Therapeutics, Inc. (NASDAQ: ADGI) fell 35.8% to $27.12. Adagio Therapeutics recently announced new data from its COVID-19 antibody program.

  • NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) dropped 28% to $2.68 after the company announced a 4.3 million share offering at $3.25 per share.

  • IronNet, Inc.. (NASDAQ: IRNT) shares fell 22.7% to $13.18 after dropping 15% on Thursday.

  • Vir Biotechnology, Inc. (NASDAQ: VIR) dropped 21.9% to $33.98 in reaction to promising data from competitor Merck's COVID-19 antiviral candidate.

  • Immunome, Inc. (NASDAQ: IMNM) fell 17.6% to $20.06. Immunome will present preclinical data on anti IL-38 antibody program at The American Association for Cancer Research NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics.

  • Benson Hill Inc. (NASDAQ: BHIL) fell 17.3% to $5.89.

  • Superior Drilling Products, Inc. (NYSE: SDPI) shares fell 16.6% to $1.4601 after jumping 60% on Thursday.

  • Guardant Health, Inc. (NASDAQ: GH) dipped 16.6% to $104.24 following a Bloomberg report suggesting the company is exploring an acquisition of NeoGenomics.

  • Clarus Therapeutics Holdings, Inc. (NASDAQ: CRXT) dropped 16.3% to $4.4591. Clarus Therapeutics filed for offer and sale of up to 19.82 million shares of common stock by selling stockholders.

  • Novavax, Inc. (NASDAQ: NVAX) fell 16.2% to $173.56 in reaction to positive data from Merck's oral antiviral molnupiravir, which reduced risk of hospitalization or death by roughly 50%.

  • Farmmi, Inc. (NASDAQ: FAMI) fell 16.1% to $0.3881. Farmmi recently agreed to acquire all the shares of Jiangxi Xiangbo Agriculture and Forestry Development Co., Ltd (Xiangbo) for about RMB70 million.

  • Lordstown Motors Corp. (NASDAQ: RIDE) shares fell 15.1% to $6.78. Lordstown Motors issued production and financial update. Foxconn will purchase $50 million of Lordstown common stock at price of $6.8983 per share.

  • CureVac N.V. (NASDAQ: CVAC) dropped 15% to $46.40 in reaction to positive data from Merck's oral antiviral molnupiravir, which reduced risk of hospitalization or death by roughly 50%.

  • Camber Energy, Inc. (NYSE: CEI) shares fell 14.7% to $3.26 after gaining over 11% on Thursday.

  • Moderna, Inc. (NASDAQ: MRNA) dropped 12.3% to $337.31 in reaction to positive data from Merck's oral antiviral molnupiravir, which reduced risk of hospitalization or death by roughly 50%. Stephane Bancel, Chief Executive Officer at Moderna, made a large insider sell on September 30, according to a new SEC filing.

  • Alzamend Neuro, Inc. (NASDAQ: ALZN) fell 11.3% to $2.73. Ascendiant Capital analyst Edward Woo initiated coverage on Alzamend Neuro with a Buy rating and announced price target of $8.

  • BioNTech SE (NASDAQ: BNTX) declined 10.2% to $245.21 in reaction to positive data from Merck's oral antiviral molnupiravir, which reduced risk of hospitalization or death by roughly 50%. BioNTech dosed the first patient with its individualized mRNA cancer vaccine BNT122 (autogene cevumeran, RO7198457) in Phase 2 clinical trial.

See more from Benzinga

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.